Drug
Aliskiren Hemifumarate
Aliskiren Hemifumarate: highest development phase Approved, developed by Novartis. 2 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| AMTURNIDE | Approved | |
| TEKAMLO | Approved |
Latest
No recent events.
Follow Aliskiren Hemifumarate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.